FOXC2 and esophageal cancer: FoxC2 expression has also been reported in esophageal cancer cells [39], and the survival rate is significantly lower for patients with high levels of FoxC2 expression than for patients with low levels of FoxC2 expression, which suggests that FoxC2 could be used as a novel, independent prognosis factor for patients with esophageal cancer [39] (Table 1).